サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1533044

欧州のフィルフィニッシュ製造：2030年市場予測- 地域別分析- 製品、モダリティ、エンドユーザー別

Europe Fill Finish Manufacturing Market Forecast to 2030 - Regional Analysis - by Product, Modality, and End User

出版日
ページ情報
英文 108 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
欧州のフィルフィニッシュ製造：2030年市場予測- 地域別分析- 製品、モダリティ、エンドユーザー別
出版日: 2024年06月05日
発行: The Insight Partners
ページ情報: 英文 108 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のフィルフィニッシュ製造市場は、2022年に24億7,326万米ドルと評価され、2030年には47億7,250万米ドルに達すると予測され、2022年から2030年までのCAGRは8.6%で成長すると予測されています。

生物製剤需要の高まりが欧州の充填剤製造市場を牽引

生物製剤は売れ筋医薬品の大半を占め、最も急成長している製薬産業分野の一つです。30年前に組換えタンパク質ベースの治療薬が発売されて以来、生物製剤市場全体は年率12%以上で成長しています。さらに、現在5,000を超えるバイオ医薬品候補が開発中です。バイオ医薬品は大きな利益率をもたらすが、高い開発コストと複雑な製造プロトコルが、これらの薬理学的介入を行うスポンサーの主な懸念事項となっています。その結果、いくつかの新興企業や製薬大手は、事業運営のさまざまなプロセスを受託サービス・プロバイダーにアウトソーシングし始めています。さらに、製造受託機関（CMO）や開発・製造受託機関（CDMO）への業務委託は、設備投資の必要性を減らし、より大きな生産能力へのアクセスを提供し、製品の市場投入までの時間を短縮し、製品の商業化に伴うリスクを低減します。

フィルフィニッシュは製造工程の最終段階であり、医薬品製造において最も重要な段階の一つです。生物製剤では、製品の完全性と安全性を確保するため、フィルフィニッシュ作業に特別な手順と設備が必要です。そのため、生物学的製剤の需要が高まるにつれ、柔軟な無菌フィルフィニッシュ技術に対するニーズが高まっています。医薬品メーカーは、最新のフィルフィニッシュ技術に関する経験と専門知識を活用するため、受託サービスプロバイダーと協力しています。現在、約180社がさまざまな生物製剤のフィルフィニッシュ製造サービスを提供しています。これらの受託製造企業は、さまざまな地域にまたがる350以上のフィルフィニッシュ工場に拠点を置いています。

欧州のフィルフィニッシュ製造市場概要

ドイツの市場企業は、市場拡大と成長のために有機的・無機的成長戦略を採用しています。例えば、2020年7月、ドイツのラベンスブルクに本社を置く開発・製造受託機関（CDMO）のVetter社は、オーストリアの臨床製造施設の購入により、充填/仕上げ能力の追加投資を行うと発表しました。

同様に、ジークフリード・グループは、革新的なCOVID-19ワクチン候補であるBNT162b2の商業用量の大規模な充填・包装に関して、ドイツの免疫療法企業であるバイオファーマシューティカル・ニュー・テクノロジーズ社と協力・供給契約を締結しました。バイオエヌテックがアメリカの製薬会社ファイザーと共同で開発したこのワクチンは、承認後、2021年半ば以降、ジークフリートがハーメルンの工場で充填する予定です。また、ドイツにあるバイオ医薬品の開発・製造受託機関（CDMO）の大手であるレンシュラー・バイオテクノロジーズ社と、無菌充填・仕上げサービスの独立系専門企業であるレンシュラー・フィル・ソリューションズ社は、戦略的提携を発表し、レンシュラー・バイオテクノロジーズ社の顧客の要件を満たすために、新しい最先端の充填・仕上げ設備とバイオ医薬品のワンストップ・ソリューションを提供することになった。

欧州のフィルフィニッシュ製造市場の収益と2030年までの予測（金額）

欧州のフィルフィニッシュ製造市場のセグメンテーション

欧州のフィルフィニッシュ製造市場は、製品、モダリティ、エンドユーザー、国に基づいてセグメント化されます。製品別では、欧州のフィルフィニッシュ製造市場は消耗品と器具に二分されます。消耗品セグメントは2022年に大きな市場シェアを占めました。さらに、消耗品はプレフィルドシリンジ、ガラスバイアル/プラスチックバイアル、カートリッジ、その他に細分化されます。

モダリティ別では、欧州のフィルフィニッシュ製造市場は組換えタンパク質、モノクローナル抗体、ワクチン、細胞療法と生物学的療法、遺伝子療法、その他にセグメント化されます。2022年にはワクチン分野が最大の市場シェアを占めました。

エンドユーザー別では、欧州のフィルフィニッシュ製造市場は、受託製造機関、バイオ製薬会社、その他に分類されます。受託製造機関セグメントが2022年に最大の市場シェアを占めました。

国別に見ると、欧州のフィルフィニッシュ製造市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツが2022年の欧州のフィルフィニッシュ製造市場シェアを独占しました。

Becton Dickinson and Co、Gerresheimer AG、Groninger and Co GmbH、IMA Industria Macchine Automatiche SpA、Maquinaria Industrial Dara SL、Nipro Medical Europe NV、NNE AS、Optima Packaging Group Gmbh、Schott AG、SGD SA、Stevanato Group SpA、Syntegon Technology GmbH、West Pharmaceutical Services Incは、欧州のフィルフィニッシュ製造市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のフィルフィニッシュ製造市場情勢

  • 概観
  • PEST分析

第5章 欧州のフィルフィニッシュ製造市場- 主要産業力学

  • フィルフィニッシュ製造市場：主要産業力学
  • 主要市場促進要因
    • 非経口投与用プレフィルドシリンジの採用拡大
    • 生物製剤に対する需要の高まり
  • 主な市場抑制要因
    • バイオ医薬品受託製造業界における競合の激化
  • 主な市場機会
    • 生物製剤の重要なパイプライン
  • 主な将来動向
    • 無菌フィルフィニッシュ用シングルユースシステム
  • 促進要因と抑制要因の影響

第6章 フィルフィニッシュ製造市場：欧州市場分析

第7章 欧州のフィルフィニッシュ製造市場分析-製品別

  • 消耗品
    • 消耗品市場、収益と2030年までの予測
  • 器具
    • 消耗品の概要
    • インストルメント市場、収益と2030年までの予測

第8章 欧州のフィルフィニッシュ製造市場分析：モダリティ別

  • 組換えタンパク質
    • 組換えタンパク質市場、収益と2030年までの予測
  • モノクローナル抗体
    • モノクローナル抗体市場、収益と2030年までの予測
  • ワクチン
    • ワクチン市場、収益と2030年までの予測
  • 細胞治療と生物学的治療
    • 細胞療法と生物学的療法の市場、収益と2030年までの予測
  • 遺伝子治療
    • 遺伝子治療市場、収益と2030年までの予測
  • その他
    • その他の概要
    • その他市場、収益と2030年までの予測

第9章 欧州のフィルフィニッシュ製造市場分析：エンドユーザー別

  • 製造受託機関
    • 受託製造機関市場、収益と2030年までの予測
  • バイオ医薬品企業
    • バイオ製薬会社の概要
    • バイオ医薬品企業の市場、収益と2030年までの予測
  • その他
    • その他の概要
    • その他の市場、収益と2030年までの予測

第10章 欧州のフィルフィニッシュ製造市場：国別分析

  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第11章 業界情勢

  • フィルフィニッシュ製造市場における成長戦略、2020年～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • IMA Industria Macchine Automatiche SpA
  • Nipro Medical Europe NV
  • Maquinaria Industrial Dara SL
  • Groninger and Co GmbH
  • SGD SA
  • Optima Packaging Group Gmbh
  • NNE AS
  • Stevanato Group SpA
  • Syntegon Technology GmbH
  • West Pharmaceutical Services Inc
  • Gerresheimer AG
  • Schott AG
  • Becton Dickinson and Co

第13章 付録

図表

List Of Tables

  • Table 1. Fill Finish Manufacturing Market Segmentation
  • Table 2. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) - Product
  • Table 3. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) - Consumables
  • Table 4. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) - Modality
  • Table 5. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) - End User
  • Table 6. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 7. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 8. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 9. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 10. Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 11. Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 12. Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 13. Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 14. France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 15. France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 16. France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 17. France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 18. Italy Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 19. Italy Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 20. Italy Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 21. Italy Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 22. Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 23. Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 24. Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 25. Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 26. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Product
  • Table 27. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Consumables
  • Table 28. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By Modality
  • Table 29. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 30. Recent Inorganic Growth Strategies in the Fill Finish Manufacturing Market
  • Table 31. Recent Organic Growth Strategies in The Fill Finish Manufacturing Market
  • Table 32. Glossary of Terms, Fill Finish Manufacturing Market

List Of Figures

  • Figure 1. Fill Finish Manufacturing Market Segmentation, By Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Fill Finish Manufacturing Market Revenue (US$ Million), 2022 - 2030
  • Figure 5. Fill Finish Manufacturing Market Share (%) - Product, 2022 and 2030
  • Figure 6. Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Fill Finish Manufacturing Market Share (%) - Modality, 2022 and 2030
  • Figure 9. Recombinant Proteins Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Monoclonal Antibodies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Vaccines Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Cell Therapies and Biological Therapies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Gene Therapies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Fill Finish Manufacturing Market Share (%) - End User, 2022 and 2030
  • Figure 16. Contract Manufacturing Organizations Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. Biopharmaceutical Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Europe Fill Finish Manufacturing Market, by Key Countries - Revenue (2022) (US$ Million)
  • Figure 20. Europe Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 21. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 22. Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 23. France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 24. Italy Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 25. Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 26. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
目次
Product Code: TIPRE00024805

The Europe fill finish manufacturing market was valued at US$ 2,473.26 million in 2022 and is expected to reach US$ 4,772.50 million by 2030; it is estimated to grow at a CAGR of 8.6% from 2022 to 2030.

Elevating Demand for Biologics Drives Europe Fill Finish Manufacturing Market

Biologics constitute a majority of the top-selling drugs, and they represent one of the fastest-growing pharmaceutical industry segments. Since the launch of recombinant protein-based therapies ~30 years ago, the overall biologics market has grown at an annual rate of more than 12%. Further, over 5,000 biopharmaceutical product candidates are currently under development. Although biopharmaceuticals offer significant profit margins, high development costs and complex production protocols are the key concerns of the sponsors of these pharmacological interventions. As a result, several start-ups and pharmaceutical giants have begun outsourcing different processes of their business operations to contract service providers. Moreover, outsourcing jobs to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) reduces the requirement of capital investments, provides access to larger production capacities, decreases the time-to-market of products, and lowers risks associated with the commercialization of products.

Fill finish is the final step in the production process, and it is one of the most crucial stages of drug manufacturing. Biologics require special procedures and equipment for fill finish operations to ensure product integrity and safety. Thus, the rise in demand for biologics has resulted in an equivalent need for flexible aseptic fill finish technologies. Pharmaceutical drug manufacturers collaborate with contract service providers to leverage their experience and expertise in the latest fill finish technologies. Fill finish manufacturing services are currently provided by approximately 180 companies for a variety of biologics. They are located in over 350 fill finish factories for these contract manufacturing companies across various geographic regions.

Europe Fill Finish Manufacturing Market Overview

The market players in Germany are adopting organic and inorganic growth strategies for market expansion and growth. For instance, in July 2020, Vetter, the contract development and manufacturing organization (CDMO), headquarters in Ravensburg, Germany, announced that it is investing in additional fill/finish capacity with the purchase of a clinical manufacturing site in Austria.

Similarly, The Siegfried Group signed a cooperation and supply agreement with Biopharmaceutical New Technologies, a German immunotherapy company, for the large-scale filling and packaging of commercial quantities of BNT162b2, an innovative COVID-19 vaccine candidate. Following successful approval, the vaccine developed by BioNTech in cooperation with Pfizer, an American pharmaceutical company, will be filled by Siegfried at its Hameln site from mid-2021 onwards. Also, Rentschler Biotechnologie GmbH, leading contract development and manufacturing organization (CDMO) for biopharmaceuticals located in Germany, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the requirements of Rentschler Biotechnologie's clients.

Europe Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

Europe Fill Finish Manufacturing Market Segmentation

The Europe fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Europe fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

By modality, the Europe fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

In terms of end user, the Europe fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the Europe fill finish manufacturing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fill finish manufacturing market share in 2022.

Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Europe fill finish manufacturing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Fill Finish Manufacturing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Fill Finish Manufacturing Market - Key Industry Dynamics

  • 5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
    • 5.2.2 Elevating Demand for Biologics
  • 5.3 Key Market Restraints
    • 5.3.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
  • 5.4 Key Market Opportunities
    • 5.4.1 Significant Pipeline for Biologics
  • 5.5 Key Future Trends
    • 5.5.1 Single-Use Systems for Aseptic Fill Finish
  • 5.6 Impact of Drivers and Restraints:

6. Fill Finish Manufacturing Market - Europe Market Analysis

7. Europe Fill Finish Manufacturing Market Analysis - Product

  • 7.1 Consumables
    • 7.1.1 Overview
    • 7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe Fill Finish Manufacturing Market Analysis - Modality

  • 8.1 Recombinant Proteins
    • 8.1.1 Overview
    • 8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Overview
    • 8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Vaccines
    • 8.3.1 Overview
    • 8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell Therapies and Biological Therapies
    • 8.4.1 Overview
    • 8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Gene Therapies
    • 8.5.1 Overview
    • 8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe Fill Finish Manufacturing Market Analysis - End User

  • 9.1 Contract Manufacturing Organizations
    • 9.1.1 Overview
    • 9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe Fill Finish Manufacturing Market - Country Analysis

  • 10.1 Europe Fill Finish Manufacturing Market Breakdown, by Country
    • 10.1.1 United Kingdom
    • 10.1.2 United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.1.2.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.2.1.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.2.2 United Kingdom Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.2.3 United Kingdom Fill Finish Manufacturing Market Breakdown by End User
    • 10.1.3 Germany
    • 10.1.4 Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.1.4.1 Germany Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.4.1.1 Germany Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.4.2 Germany Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.4.3 Germany Fill Finish Manufacturing Market Breakdown by End User
    • 10.1.5 France
    • 10.1.6 France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.1.6.1 France Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.6.1.1 France Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.6.2 France Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.6.3 France Fill Finish Manufacturing Market Breakdown by End User
    • 10.1.7 Italy
      • 10.1.7.1 Italy Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.7.1.1 Italy Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.7.2 Italy Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.7.3 Italy Fill Finish Manufacturing Market Breakdown by End User
    • 10.1.8 Spain
    • 10.1.9 Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.1.9.1 Spain Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.9.1.1 Spain Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.9.2 Spain Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.9.3 Spain Fill Finish Manufacturing Market Breakdown by End User
    • 10.1.10 Rest of Europe
    • 10.1.11 Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.1.11.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Product
        • 10.1.11.1.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Consumables
      • 10.1.11.2 Rest of Europe Fill Finish Manufacturing Market Breakdown by Modality
      • 10.1.11.3 Rest of Europe Fill Finish Manufacturing Market Breakdown by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 IMA Industria Macchine Automatiche SpA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Nipro Medical Europe NV
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Maquinaria Industrial Dara SL
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Groninger and Co GmbH
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 SGD SA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Optima Packaging Group Gmbh
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 NNE AS
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Product & Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Stevanato Group SpA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Syntegon Technology GmbH
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 West Pharmaceutical Services Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Gerresheimer AG
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Schott AG
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Becton Dickinson and Co
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms